| 摘要 |
The present invention provides methods of treating schizophrenia and/or glucoregulatory abnormalities in a patient in need thereof comprising administering to said patient a therapeutically effective amount of a compound of formula (I) wherein m is 0, 1 or 2; n is 0, 1 or 2; p is 0 or 1; each R is independently hydrogen, halogen, trifluoromethyl, C<sub |
| 申请人 |
AVENTIS PHARMACEUTICALS INC.;SMITH, CRAIG, P.;RAMPE, DAVID, E.;BOROWSKY, BETH;KONGSAMUT, SATHAPANA |
发明人 |
SMITH, CRAIG, P.;RAMPE, DAVID, E.;BOROWSKY, BETH;KONGSAMUT, SATHAPANA |
